Literature DB >> 25198262

Association of age and parity with intrauterine device expulsion.

Tessa Madden1, Colleen McNicholas, Qiuhong Zhao, Gina M Secura, David L Eisenberg, Jeffrey F Peipert.   

Abstract

OBJECTIVE: To investigate whether age 14 to 19 years and nulliparity are associated with expulsion of levonorgestrel and copper intrauterine devices (IUDs).
METHODS: This was a planned secondary analysis of the Contraceptive CHOICE Project. We used Kaplan-Meier survival analysis to estimate expulsion rates for the first levonorgestrel or copper IUD received during study participation. Cox proportional hazards regression models were used to investigate baseline characteristics associated with expulsion.
RESULTS: A total of 5,403 females were included; 4,219 (78%) used the levonorgestrel IUD and 1,184 (22%) used the copper IUD. There were 432 initial expulsions reported. The 36-month cumulative expulsion rate was 10.2 per 100 IUD users and did not vary by IUD type (levonorgestrel IUD 10.1 compared with copper IUD 10.7, P=.99). In the bivariate analysis, multiple characteristics including age, nulliparity, immediate postabortion insertion, and heavy menses were associated with expulsion. The cumulative rate of expulsion was lower in nulliparous women compared with parous women (8.4 compared with 11.4; P<.001) and higher in females aged 14 to 19 compared with older women (18.8 compared with 9.3; P<.001). After adjusting for confounders and stratifying by IUD type, the hazard ratio of expulsion for females aged 14 to 19 years was 2.26 (95% confidence interval [CI] 1.68-3.06) for the levonorgestrel IUD and 3.06 (95% CI 1.75-5.33) for the copper IUD. Compared to parous levonorgestrel IUD users, expulsion was lower for nulliparous levonorgestrel IUD users (adjusted hazard ratio 0.59, 95% CI 0.44-0.78).
CONCLUSION: IUD expulsions were not increased in nulliparous females. More expulsions were observed in females aged 14 to 19 compared with older women regardless of parity or IUD type. LEVEL OF EVIDENCE: : II.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25198262      PMCID: PMC4172535          DOI: 10.1097/AOG.0000000000000475

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  18 in total

1.  Contraception for Adolescents: Focusing on Long-Acting Reversible Contraceptives (LARC) to Improve Reproductive Health Outcomes.

Authors:  Bliss Kaneshiro; Jennifer Salcedo
Journal:  Curr Obstet Gynecol Rep       Date:  2015-01-28

2.  "A Résumé for the Baby": Biosocial Precarity and Care of Substance-Using, Pregnant Women in San Francisco.

Authors:  Ashish Premkumar; Jennifer Kerns; Megan J Huchko
Journal:  Cult Med Psychiatry       Date:  2020-03

3.  Women's willingness and ability to feel the strings of their intrauterine device.

Authors:  Juliana Melo; Mary Tschann; Reni Soon; Melissa Kuwahara; Bliss Kaneshiro
Journal:  Int J Gynaecol Obstet       Date:  2017-04-08       Impact factor: 3.561

Review 4.  Eliminating health disparities in unintended pregnancy with long-acting reversible contraception (LARC).

Authors:  Caitlin Parks; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2016-02-12       Impact factor: 8.661

5.  One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception.

Authors:  J N Sanders; D K Turok; P A Royer; I S Thompson; L M Gawron; K E Storck
Journal:  Contraception       Date:  2017-06-05       Impact factor: 3.375

Review 6.  The safety of intrauterine devices among young women: a systematic review.

Authors:  Tara C Jatlaoui; Halley E M Riley; Kathryn M Curtis
Journal:  Contraception       Date:  2016-10-19       Impact factor: 3.375

7.  Continuation of Copper T in Immediate Postplacental, Immediate Postabortal and Interval Period of Insertion.

Authors:  Banashree Nath; Harsha S Gaikwad; Kashika Nagpal
Journal:  J Obstet Gynaecol India       Date:  2021-05-28

8.  Levonorgestrel Intrauterine Device Use in Overweight and Obese Women.

Authors:  Lynne Y Saito-Tom; Reni A Soon; Sara C Harris; Jennifer Salcedo; Bliss E Kaneshiro
Journal:  Hawaii J Med Public Health       Date:  2015-11

9.  Efficacy and Safety of Long-Acting Reversible Contraception in Women With Cardiovascular Conditions.

Authors:  Quyen Vu; Elizabeth Micks; Erin McCoy; Sarah Prager
Journal:  Am J Cardiol       Date:  2015-11-05       Impact factor: 2.778

10.  Comparing options for females seeking permanent contraception in high resource countries: a systematic review.

Authors:  Rebecca Gormley; Brian Vickers; Brooke Cheng; Wendy V Norman
Journal:  Reprod Health       Date:  2021-07-20       Impact factor: 3.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.